Abstract: Diterpenoids are the focus of natural product drug discovery because of their great structural diversity and pronounced biological activities. Euphorbia fischeriana Steud is a Chinese traditional medicinal herb for curing edema, ascites, and cancer. This plant contains rich diterpenoids. Based on the carbon skeleton and substituents, it can be classified into thirteen subtypes: ent-abietane, daphnane, tigliane, ingenane, ent-atisane, ent-rosane, ent-kaurene, ent-kaurane, secotigliane, lathyrane, ent-pimarene, isopimarene and dimeric. In this paper, we reviewed the chemical structures and biological activities of 90 diterpenoids isolated from this medicinal herb. We hope that this work can serve as a reference for further research of these diterpenoids and lay the foundation for drug discovery.
Introduction
Euphorbia fischeriana Steud is a perennial herbaceous plant belonging to the family Euphorbiaceae, which is primarily distributed in northeastern mainland China [1] . The dried plant roots of E. fischeriana in traditional Chinese medicine, have been used as a remedy for the treatment of ailments, including edema, ascites and cancer [2] [3] [4] . The main components of E. fischeriana are diterpenoids, triterpenes, steroids, aromatic compounds and tannins [3] . Among them, diterpenoids are the primary bioactive constituents of this plant. Diterpenoids are a focus of natural product drug discovery because of their great structural diversity and pronounced biological activities [5] . In the last few years, a tigliane-type diterpenoid prostratin extracted from the roots of E. fischeriana has attracted great interest because of its unique ability to activate latent viral reservoirs and protect healthy cells from infection [5, 6] . It is a protein kinase C activator that can reactivate HIV-1 latency and help to avoid the new infection of CD4+ Cells [5, 6] . It brings new hope for the treatment of HIV. This result encouraged us to screen more bioactive diterpenoids from E. fischeriana for disease treatment.
In this review article, we focus on the structures and biological activities of 90 diterpenoids with different structures derived from E. fischeriana. We hope this work can serve as a reference for drug discovery. diterpenoids include ent-abietane, daphnane, tigliane, ingenane, ent-atisane, ent-rosane, ent-kaurene, ent-kaurane, secotigliane lathyrane, ent-pimarene, isopimarene and dimeric. Their names, subtypes and corresponding references are compiled in Table 1 . Their chemical structures are shown in Figure 1 . 
Biological Activities of Diterpenoids
Diterpenoids isolated from E. fischeriana exert many different activities, including antitumor, anti-inflammatory, anti-HIV-1, feeding deterrent and others.
Antitumor Activity
Many investigations have been performed on the antitumor activity of diterpenoids from E. fischeriana. Compounds with different skeletal types (e.g., abietane, ingenane, tigliane and lathyrane) proved to have moderate or strong antiproliferative effects on different human cancer cell lines [5, 15] . Jolkinolide B (1), a typical ent-abietane-type diterpenoid isolated from E. fischeriana, was found to induce time-and dose-dependent cytotoxicity in cells derived from liver [18] , breast [19, 20] , gastric [18] , cervical cancers [18] , as well as human leukemic [21, 22] . The anticancer effect of Jolkinolide B are associated with various kinds of mechanisms. Jolkinolide B is capable of inducing apoptosis in breast cancer cells through inhibition of the PI3K/Akt signaling pathway [19, 20] . It can block cell cycles at G1 in human myeloid Leukemic cell K562 [22] . Moreover, it restrains the metastasis in breast cancer MDA-MB-231 cells through suppression of β 1 -integrin expression and phosphorylation of focal adhesion kinase (FAK) [23] . 17-Acetoxyjolkinolide B (4), has the potential to irreversibly inhibit IκB kinase and induce apoptosis of tumor cells. Nuclear factor-κB (NF-κB) plays an important role in tumor cell survival, growth, angiogenesis, and metastasis. 17-Acetoxyjolkinolide B is a novel type of anticancer drug candidate, as a NF-κB pathway inhibitor [24] . 17-Hydroxyjolkinolide B (5), a natural bioactive molecule, exerts its cytotoxicity against liver [18] , breast 18], gastric [18] , cervical [18] , lung [18] , ovarian [25] , prostate [25] , colorectal [25] , cervix cancers [25] . Thorough examination proved that 17-hydroxyjolkinolide B can inhibit signal transducers and activators of transcription 3 signaling by covalently cross-linking Janus kinases and induce apoptosis of human cancer cells [25] . 12-deoxyphorbol 13-palmitate (32), a tigliane-type diterpenoid isolated from E. fischerian is another effective antineoplastic compound. 12-Deoxyphorbol 13-palmitate was found to mediate cell growth inhibition, G2-M cell cycle arrest and apoptosis in BGC823 cells [26] . It also reportedly has the ability to inhibit VEGF induced angiogenesis via suppression of VEGFR-2-signaling pathway [27] . Three ingenol diterpenoids including ingenol 3-palmitate (76), ingenol-3-myristinate (77), ingenol 6,7-epoxy-3-tetradecanoate (80) showed significant cytotoxicity against A549 with IC 50 value of 3.35, 2.85, 2.88 µg/mL, respectively [2] . Two ent-atisane-type diterpenoids ent-1β,3β,16β,17-tetrahydroxyatisane (60), ent-1β,3α,16β,17-tetrahydroxyatisane (61) showed inhibitory effects against MCF-7 with IC 50 levels of 23.21 and 15.42 mM [15] . Moreover, 13 diterpenoids, including jolkinolide B (1), euphorin E (9), euphorin H (12), yuexiandajisu E (22), ebractenoid C (48), ebractenoid F (52), euphorinC (53), ent-3β-hydroxyatis-16-ene-2,14-dione (71), 19-O-β-Dglucopyranosyl-ent-atis-16-ene-3,14-dione (73), ingenol-3-palmitate (76), ingenol-3-myristinate (77), ingenol-20-myristinate (79), and jolkinol A (88) showed inhibitory activity on mammosphere formation in human breast cancer MCF-7 cells at a final concentration of 10 µM, suggesting the potential of these bioactive diterpenoids for further investigation of the action targeting cancer stem cells [7, 16] . The previous article provide more detailed descriptions about the anticancer mechanisms of these bioactive diterpenoids [28] .
Anti-Inflammatory
Jolkinolide B (1) was reported to have a protective effect on LPS-induced ALI in mice [29] . It was revealed that jolkinolide B significantly inhibited LPS-induced histological alterations, lung edema, inflammatory cell infiltration, myeloperoxidase (MPO) activity [29] . At the molecular level, jolkinolide B reduced the production of TNF-α, IL-6 and IL-1β. Furthermore jolkinolide B was shown to inhibit LPS-induced the degradation of IκBα and phosphorylation of NF-κB p65 and MAPK [29] . 17-Hydroxy-jolkinolide B (5) was found to a potential anti-inflammatory drug candidate. It can inhibit LPS-induced the production of PGE 2, NO, IL-6, and TNF-α in RAW264 cells. 17-Hydroxy-jolkinolide B has the ability to reduce the expression of COX-2, iNOS, IL-6, and TNF-α gene through the suppression of MAPK phosphorylation and NF-κB activation. In addition, it induced the HO-1 expression [30] . Five diterpenoids including jolkinolide B (1), 11β-hydroxy-8,14-epoxy-ent-abieta-13(15)-en-16,12α-olide (8), yuexiandajisu D (23), ebractenoid F (52), jolkinol A (88) exhibited promising inhibitory effects on NO production in LPS-induced RAW 264.7 macrophages [8] . These compounds may be worthy of further investigation for the treatment of inflammatory diseases associated with enhanced production of NO [8] . Here, these studies are summarized in Table 2 . 
Anti-HIV-1
Prostratin (28), a tigliane-type diterpenoid, has been shown to be highly effective in inducing HIV-1 reactivation in latent reservoirs of infected Jurkat-LAT-GFP cells [5, 31] . Five tigliane-type diterpenoids, including prostratin (28), fischeroside A (37), fischeroside B (38), fischeroside C (39), 12-deoxyphorbol-13,20-diacetate (40), were tested for cytotoxicities against C8166 cells. Compounds 37-39 showed weak activity in preventing the cytopathic effects of HIV-1 in C8166 cells [12] . Prostratin exerted the strongest anti-HIV-1 activity, with an EC 50 of 0.00006 µM and a TI of 8500 [12] . 12-Deoxyphorbol-13,20-diacetate displayed anti-HIV-1 activity, with an EC 50 of 0.003 µM and a TI of 366.67 [12] . This assay demonstrated that introducing an O-acetyl or glucopyranosyl moiety at C-20 of prostratin may dramatically reduce its anti-HIV-1 activity [12] .
Feeding Deterrent
Feeding deterrent activities of 17-hydroxyjolkinolide A (3), 17-hydroxyjolkinolide B (5), jolkinolide B (1), 12-deoxyphorbol 13-(9Z)-octadecenoate 20-acetate (34) have been studied against two stored-product insects, T. castaneum and S. zeamais [4] . The experiment results are shown in Table 3 . Jolkinolide B exhibited significant feeding deterrent activity against S. zeamais (EC 50 = 342.1) and T. castaneum adults (EC 50 = 361.4) [4] . . These compounds could be applied to slow down the glucose level for diabetes [13] . 17-Hydroxyjolkinolide B (3) exhibited an inhibitory effect against mycobacterium smegmatis [1] . This means that it possesses a potential antituberculosis effect [1] . 17-Hydroxy-jolkinolide A (5) exerted an inhibitory effect on bone loss by preventing osteoclast formation and bone resorption [32] . 17-Hydroxy-jolkinolide A (5) treatment led to down-regulation of the expression of tartrate-resistant acid phosphatase (TRAP), cathepsin K (Cts K) and MMP-9 [32] . This compound may be useful as a therapeutic reagent for bone loss-associated diseases [32] . Here, we summarize these studies in Table 4 . 
Conclusions
Natural plants contain a variety of bioactive compounds. They are frequently used as drugs or lead compounds in drug development. Almost 70% of modern drugs have a natural product origin [5, 33, 34] . Therefore, searching for compounds with important biological activities from natural plants is of great significance. Diterpenoids are a constant focus of drug discovery because of their great structural diversity, resulting in various bioactivities. E. fischeriana is especially rich in diterpenoids [34] . In this paper, we have summarized 90 diterpenoids that have been isolated and identified from E. fischeriana, many of which are novel diterpenoids. Up to now, the majority of these diterpenoids have not been studied in terms of their biological activities. We hope to discover more potential drug leads in the future study. The mechanisms of bioactive ingredients from E. fischeriana need deeper research. Thoroughly understanding the targets for active compounds will help us to design effective new drugs. This review provides reference for further research of these diterpenoids and lays the foundation for drug discovery.
